微載體市場- 按產品（消耗品{介質、微載體珠}、設備{生物反應器、細胞計數器}）、應用（生物製藥生產、再生醫學）、最終用戶（CRO、研究機構）、全球預測， 2024 - 2032 年

Microcarriers Market - By Products (Consumables {Media, Microcarrier Beads}, Equipment {Bioreactor, Cell Counter}), Application (Biopharmaceutical Production, Regenerative Medicine), End-user (CROs, Research Institutes), Global Forecast, 2024 - 2032

出版日期: 2024年02月07日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

受細胞培養過程中擴大採用微載體、研發活動的進步、傳統細胞培養過程之外的應用擴展以及對基於細胞的療法和生物製劑的需求不斷成長的推動，全球微載體市場規模將於2024-2032 年以9.5% 的複合年成長率成長。

城市化導致對醫療保健服務的需求增加，包括利用細胞技術的先進醫療和療法。據世界銀行稱，目前，全球至少有一半人口居住在城市地區。資料顯示，2045年，全球城市人口將激增1.5倍，達到60億。隨著越來越多的人遷移到城市地區，對生物製藥產品、再生醫學和個人化治療的需求越來越大，以滿足人口稠密的城市社區的醫療保健需求。這一趨勢推動了對微載體的需求，微載體對於生產用於治療城市環境中流行的各種疾病的細胞療法、疫苗和生物製劑至關重要。

微載體市場根據設備、產品、應用、最終用戶和地區進行分類。

到 2032 年，設備領域將大幅成長，因為基於微載體的細胞培養系統的先進設備和技術的可用性提高了製程效率、可擴展性和可重複性。生物反應器、旋轉瓶和細胞培養容器等設備可支持微載體上的細胞培養，有助於生產大量用於各種應用的細胞。隨著生物製藥和生物技術公司投資最先進的設備來最佳化細胞培養過程，預計該細分市場將進一步成長。

到 2032 年，再生醫學領域將佔據相當大的微載體市場佔有率，因為微載體用於再生醫學應用，包括組織工程、細胞治療和器官再生。這些生物相容性支架提供了有利於細胞附著、增殖和分化的3D微環境，從而能夠開發先進的再生療法。隨著對個人化醫療和慢性病治療的日益關注，再生醫學應用中對微載體的需求預計將進一步飆升，推動市場擴張。

在生物製藥研發投資增加、生物技術產業不斷擴大以及細胞療法需求不斷成長的推動下，亞太地區微載體產業將在 2032 年實現令人稱道的成長。中國、印度、韓國和日本等國家處於生物製藥創新和再生醫學研究的前沿，為成長做出了貢獻。此外，支持性的政府措施、有利的監管環境以及學術界和工業界之間的合作進一步推動了該地區的市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 癌症和慢性病病例不斷增加
  - 細胞培養技術的進步
  - 生物技術和生命科學領域的投資不斷增加
- 產業陷阱與挑戰
  - 生物相容性和免疫原性問題
  - 無血清培養基成本高
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀錶板

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

主要趨勢
耗材
- 微載體珠
  - 膠原蛋白塗層珠
  - 陽離子珠
  - 蛋白質包被的珠子
  - 未經處理的珠子
  - 其他微載體珠
- 媒體
  - 血清培養基
  - 無血清培養基
  - 其他媒體
- 試劑
- 其他消耗品
裝置
- 生物反應器
  - 免洗生物反應器
  - 不銹鋼生物反應器
- 培養容器
- 細胞計數器
- 過濾系統
- 其他設備

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
生物製藥生產
- 疫苗生產
- 治療藥物生產
再生醫學
其他應用

第 7 章：市場估計與預測：按最終用戶分類，2018 年 - 2032 年

主要趨勢
製藥和生物技術公司
CRO 和 CMO
學術及研究機構
細胞庫

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 9 章：公司簡介

Bio-Rad Laboratories, Inc.
Corning Incorporated
Cytiva
denovoMATRIX GmbH
Eppendorf AG
Fujiform Holdings Corporation
Lonza Group AG
Merck KGaA
Sartorious AG
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 8058

Global Microcarrier Market Size will grow at 9.5% CAGR during 2024-2032, driven by Increasing adoption of microcarriers in cell culture processes, advancements in R&D activities, expanding applications beyond traditional cell culture processes, and rising demand for cell-based therapies and biologics.

Urbanization leads to an increase in demand for healthcare services, including advanced medical treatments and therapies that utilize cell-based technologies. According to the World Bank, currently, at least half of the global population resides in urban areas. As per data, by 2045, the world's urban population will surge by 1.5 times to reach 6 billion. As more people move to urban areas, there is a greater need for biopharmaceutical products, regenerative medicine, and personalized therapies to address the healthcare needs of densely populated urban communities. This trend drives the demand for microcarriers, which are essential in the production of cell-based therapies, vaccines, and biologics used to treat various diseases prevalent in urban settings.

The Microcarrier Market is classified based on equipment, product, application, end-user, and region.

The equipment segment will grow substantially by 2032, as the availability of advanced equipment and technologies for microcarrier-based cell culture systems enhances process efficiency, scalability, and reproducibility. Equipment such as bioreactors, spinner flasks, and cell culture vessels support the cultivation of cells on microcarriers, facilitating the production of large quantities of cells for various applications. As biopharmaceutical and biotechnology companies invest in state-of-the-art equipment to optimize cell culture processes, further segment growth is anticipated.

The regenerative medicine segment will capture a decent Microcarrier Market share by 2032, as microcarriers are used in regenerative medicine applications, including tissue engineering, cell therapy, and organ regeneration. These biocompatible scaffolds provide a three-dimensional microenvironment conducive to cell attachment, proliferation, and differentiation, enabling the development of advanced regenerative therapies. With the growing focus on personalized medicine and the treatment of chronic diseases, the demand for microcarriers in regenerative medicine applications is expected to further soar, driving market expansion.

Asia Pacific Microcarriers Industry will register commendable growth through 2032, driven by increasing investment in biopharmaceutical research and development, expanding biotechnology industry, and rising demand for cell-based therapies. Countries like China, India, South Korea, and Japan are at the forefront of biopharmaceutical innovation and regenerative medicine research, contributing to the growth. Additionally, supportive government initiatives, a favorable regulatory environment, and collaborations between academia and industry further propel market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculation
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing cases of cancer and chronic diseases
  - 3.2.1.2 Advancements in cell culture technologies
  - 3.2.1.3 Rising investments in biotechnology and life sciences
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Biocompatibility and immunogenicity concerns
  - 3.2.2.2 High cost associated with serum-free media
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Consumables
- 5.2.1 Microcarrier beads
  - 5.2.1.1 Collagen coated beads
  - 5.2.1.2 Cationic beads
  - 5.2.1.3 Protein coated beads
  - 5.2.1.4 Untreated beads
  - 5.2.1.5 Other microcarrier beads
- 5.2.2 Media
  - 5.2.2.1 Serum based media
  - 5.2.2.2 Serum-free media
  - 5.2.2.3 Other media
- 5.2.3 Reagents
- 5.2.4 Other consumables
5.3 Equipment
- 5.3.1 Bioreactor
  - 5.3.1.1 Single-use bioreactor
  - 5.3.1.2 Stainless steel bioreactor
- 5.3.2 Culture vessel
- 5.3.3 Cell counter
- 5.3.4 Filtration system
- 5.3.5 Other equipment

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Biopharmaceutical production
- 6.2.1 Vaccine production
- 6.2.2 Therapeutics production
6.3 Regenerative medicine
6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 CROs & CMOs
7.4 Academic & research institutes
7.5 Cell banks

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa